Cargando…
Gastric Cancer in the Era of Precision Medicine
Gastric cancer (GC) remains the third most common cause of cancer death worldwide, with limited therapeutic strategies available. With the advent of next-generation sequencing and new preclinical model technologies, our understanding of its pathogenesis and molecular alterations continues to be revo...
Autores principales: | Liu, Xi, Meltzer, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404028/ https://www.ncbi.nlm.nih.gov/pubmed/28462377 http://dx.doi.org/10.1016/j.jcmgh.2017.02.003 |
Ejemplares similares
-
Progress of Gastric Cancer Surgery in the era of Precision Medicine
por: Wang, Yumin, et al.
Publicado: (2021) -
Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers
por: Chen, Yanyan, et al.
Publicado: (2020) -
Precision medicine in gastric cancer
por: Bonelli, Patrizia, et al.
Publicado: (2019) -
Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine
por: Choi, Yoon Young, et al.
Publicado: (2015) -
Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)